{
  "ticker": "BDX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02965423",
  "id": "02965423",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250703",
  "time": "0831",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250703/pdf/06ldxr7dpvt5js.pdf",
  "summary": "- **Strategic partnership** with Cancer Care Associates (CCA) to accelerate adoption of BREASTEST plus\u2122.  \n- **Revenue generation** expected to commence in FY2026 via CCA network.  \n- **Key objective**: Expand clinical validation, support reimbursement discussions, and broaden market access.  \n- **Includes joint education campaign** targeting healthcare providers and patients.  \n\n*No material financial or capital structure impacts identified.*",
  "usage": {
    "prompt_tokens": 1321,
    "completion_tokens": 85,
    "total_tokens": 1406,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-02T22:46:35.704734"
}